Clinical Trials Directory

Trials / Completed

CompletedNCT04456907

Systemic Effects After Local Injection of Platelet-rich Plasma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
Male
Age
Healthy volunteers
Accepted

Summary

Objective Platelet-rich plasma (PRP) is widely utilized in the treatment of sports injuries with favorable outcomes. However, potential systemic effects after localized PRP injection are unclear at present. Design: prospective randomized study Methods Twenty-four Taiwanese male athletes with tendinopathy were randomized into a PRP group (n = 13) or a saline group (n = 11).

Conditions

Interventions

TypeNameDescription
OTHERplatelet rich plasmaAutologous platelet-rich plasma (PRP) was prepared using the RegenKit THT system (RegenLab SA, Le Mont-sur-Lausanne, Switzerland) following the manufacturer's instructions. Medical technicians, who had been well-trained by the manufacturer, were responsible for the process of PRP preparation. For each patient, 8-10 mL of venous blood was drawn and collected to the commercial RegnLab THT tube, which contained 1 mL sodium citrate. After single centrifugation at 3400 revolutions per minute (rpm) for 8 minutes, 4-5 mL of PRP was yielded with leukocytes maintained at physiological levels and red blood cells depleted. Then, the blood components were separated, with the platelet pellet resting on the separating gel. PRP for later application was obtained by re-suspending the platelet pellet in the plasma supernatant by gently inverting the unopened RegenKit THT tube 5 to 10 times.
OTHERsaline injectionsaline injection

Timeline

Start date
2017-09-22
Primary completion
2017-11-21
Completion
2018-03-28
First posted
2020-07-07
Last updated
2020-07-07

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04456907. Inclusion in this directory is not an endorsement.